Stimulating debate in the field of addiction

Addiction. 2012 Feb;107(2):253. doi: 10.1111/j.1360-0443.2011.03717.x.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Dopamine Agents / adverse effects*
  • Humans
  • Levodopa / adverse effects*
  • Parkinson Disease / drug therapy*
  • Substance-Related Disorders / diagnosis*

Substances

  • Antiparkinson Agents
  • Dopamine Agents
  • Levodopa